Medications ›daunorubicin citrate liposome

daunorubicin citrate liposome

RxCUI 221087 precise ingredient

Contraindicated with · 22

Diagnoses11

Pancytopenia Neutropenia Agranulocytosis Leukopenia Thrombocytopenia Cytopenia Heart Failure Arrhythmias, Cardiac Pregnancy Reproduction Drug Hypersensitivity

Condition families11

Leukocyte Disorders Blood Platelet Disorders Hematologic Diseases Heart Diseases Reproductive Physiological Phenomena Hemic and Lymphatic Diseases Cardiovascular Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms Drug-Related Side Effects and Adverse Reactions Chemically-Induced Disorders

Indicated for · 30

Diagnoses9

Neoplasms, Vascular Tissue Sarcoma, Kaposi Precursor Cell Lymphoblastic Leukemia-Lymphoma Leukemia, Myeloid, Acute Sarcoma Leukemia, Lymphoid Leukemia, Myeloid Neoplasms, Connective and Soft Tissue Leukemia

Condition families21

MED-RT, published by the VA through NLM. Relationships attach at the ingredient level, not to a specific product or dose.

RADV audits Coding jobs Chart counter Hours & decimal time About Contact Help Terms Privacy

Innova Coding Suite extension — both tools in your browser: Add to Chrome · Add to Edge

InnovaRx — Innova Health Strategies. ICD-10-CM and the CMS-HCC risk adjustment models are published by CMS and NCHS and are in the public domain. Effective date 2026-10-22 travels in the URL, so this link shows anyone exactly what you see.